227939-23-3

Basic information

• Product Name: 3-Pyridinecarboxaldehyde, 5-ethoxy- (9CI)
• Synonyms: 3-Pyridinecarboxaldehyde, 5-ethoxy- (9CI);5-Ethoxynicotinaldehyde;3-Ethoxy-5-formylpyridine
• CAS NO: 227939-23-3
• Molecular Formula: C8H9NO2
• Molecular Weight: 151.16256
• Product Categories: ALDEHYDE
• Mol File: 227939-23-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Pyridinecarboxaldehyde, 5-ethoxy- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxaldehyde, 5-ethoxy- (9CI)(227939-23-3)
• EPA Substance Registry System: 3-Pyridinecarboxaldehyde, 5-ethoxy- (9CI)(227939-23-3)

Safety Data

• Hazardous Substances Data: 227939-23-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
3-Pyridinecarboxaldehyde, 5-ethoxy(9CI) is utilized as a building block in organic synthesis for the preparation of heterocyclic compounds. Its diverse chemical structure and reactivity contribute to the creation of a wide range of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-Pyridinecarboxaldehyde, 5-ethoxy(9CI) serves as an important intermediate for the development of new drugs and active pharmaceutical ingredients. Its unique properties and reactivity allow for the exploration of novel therapeutic agents with potential applications in various medical fields.
Used in Agrochemical Production:
3-Pyridinecarboxaldehyde, 5-ethoxy(9CI) is also employed in the agrochemical sector, where it is used as a precursor in the synthesis of various agrochemicals. Its versatility in chemical reactions enables the development of new compounds with potential applications in crop protection and pest control.
Overall, 3-Pyridinecarboxaldehyde, 5-ethoxy(9CI) is a multifaceted chemical compound with applications spanning across different industries, including organic synthesis, pharmaceutical research, and agrochemical production, due to its unique chemical properties and versatile reactivity.

Upstream product

• 17117-17-8 5-bromo-3-ethoxypyridine 
• 68-12-2 N,N-dimethyl-formamide 

Relevant articles and documents

NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF

There is provided a morpholine derivative represented by General Formula [1A] or a salt thereof. (In the formula, a ring A represents a ring represented by General Formula [I]; * represents a bonding position; Z2 represents CH or the like; Z1 represents CR6 or the like; R6 represents a hydrogen atom or the like; X1 represents CHR7 or the like; R7 represents a hydrogen atom or the like; X2 represents CH2 or the like; R1 and R2 are the same as or different from each other, and each of R1 and R2 represents a hydrogen atom or the like; R3, R4, and R5 are the same as or different from each other, and each of R3, R4, and R5 represents a hydrogen atom, NRaRb, or the like; and each of Ra and Rb represents a hydrogen atom, a C1-8 alkyl group which may have a substituent, or the like.)

INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH

Provided herein are compounds having TNFα and/or PDE4 and/or B-RAF inhibitory activity, and compositions thereof. In particular, provided herein are compounds of the formula (I) and pharmaceutically acceptable salts, solvates, hydrates, clathrates, stereoisomers, polymorphs and prodrugs thereof, wherein Ar, R1, R2, R3, R4, n and Z are as described herein. Further provided herein are methods for treating or preventing various diseases and disorders by administering to a patient one or more TNFα and/or PDE4 and/or B-RAF inhibitors. In particular, provided herein are methods for preventing or treating cancer, inflammatory disorders, cognition and memory disorders and autoimmune disorders, or one or more symptoms thereof by administering to a patient one or more TNFα and/or PDE4 and/or B-RAF inhibitors.